ZA935795B - Substituted quinol-2-yl-methozy-phenylacetic acid derivatives. - Google Patents

Substituted quinol-2-yl-methozy-phenylacetic acid derivatives.

Info

Publication number
ZA935795B
ZA935795B ZA935795A ZA935795A ZA935795B ZA 935795 B ZA935795 B ZA 935795B ZA 935795 A ZA935795 A ZA 935795A ZA 935795 A ZA935795 A ZA 935795A ZA 935795 B ZA935795 B ZA 935795B
Authority
ZA
South Africa
Prior art keywords
carbon atoms
chain
straight
hydroxyl
phenyl
Prior art date
Application number
ZA935795A
Other languages
English (en)
Inventor
Michael Matzke
Klaus-Helmut Mohrs
Siegfried Raddatz
Romanis Fruchtmann
Reiner Mueller-Peddinghaus
Armin Hatzelmann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA935795B publication Critical patent/ZA935795B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
ZA935795A 1992-08-11 1993-08-10 Substituted quinol-2-yl-methozy-phenylacetic acid derivatives. ZA935795B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226519A DE4226519A1 (de) 1992-08-11 1992-08-11 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate

Publications (1)

Publication Number Publication Date
ZA935795B true ZA935795B (en) 1994-03-07

Family

ID=6465285

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935795A ZA935795B (en) 1992-08-11 1993-08-10 Substituted quinol-2-yl-methozy-phenylacetic acid derivatives.

Country Status (22)

Country Link
US (1) US5597833A (xx)
EP (1) EP0582908B1 (xx)
JP (1) JPH06157463A (xx)
KR (1) KR940003936A (xx)
CN (1) CN1087337A (xx)
AT (1) ATE166645T1 (xx)
AU (1) AU668574B2 (xx)
CA (1) CA2103521A1 (xx)
CZ (1) CZ151193A3 (xx)
DE (2) DE4226519A1 (xx)
DK (1) DK0582908T3 (xx)
ES (1) ES2117070T3 (xx)
FI (1) FI933512A (xx)
HU (1) HUT70041A (xx)
IL (1) IL106622A (xx)
MX (1) MX9304582A (xx)
MY (1) MY108877A (xx)
NO (1) NO179513C (xx)
NZ (1) NZ248343A (xx)
PL (1) PL300026A1 (xx)
SK (1) SK86593A3 (xx)
ZA (1) ZA935795B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US6069151A (en) * 1996-11-06 2000-05-30 Darwin Discovery, Ltd. Quinolines and their therapeutic use
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
KR20070001922A (ko) 2003-12-12 2007-01-04 와이어쓰 심장혈관질환 치료에 유용한 퀴놀린
TW200740435A (en) * 2005-08-10 2007-11-01 Takeda Pharmaceuticals Co Therapeutic agent for diabetes
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
CN106456624B (zh) 2014-02-04 2020-05-22 生物制药合伙公司 Flap抑制剂的降低中枢神经系统内的神经炎症介导的损伤的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5232916A (en) * 1988-06-27 1993-08-03 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
JPH0742488Y2 (ja) * 1989-05-23 1995-10-04 川崎重工業株式会社 移動床型脱じん・反応装置
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
US5358955A (en) * 1992-10-30 1994-10-25 Abbott Laboratories Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
NO179513C (no) 1996-10-23
MX9304582A (es) 1994-02-28
EP0582908A1 (de) 1994-02-16
NO932709L (no) 1994-02-14
FI933512A0 (fi) 1993-08-09
JPH06157463A (ja) 1994-06-03
MY108877A (en) 1996-11-30
IL106622A (en) 1997-02-18
FI933512A (fi) 1994-02-12
DE4226519A1 (de) 1994-02-17
AU4425393A (en) 1994-02-17
HU9302313D0 (en) 1993-10-28
PL300026A1 (en) 1994-03-21
NO932709D0 (no) 1993-07-27
CZ151193A3 (en) 1994-03-16
HUT70041A (en) 1995-09-28
DK0582908T3 (da) 1999-01-18
EP0582908B1 (de) 1998-05-27
DE59308603D1 (de) 1998-07-02
ES2117070T3 (es) 1998-08-01
ATE166645T1 (de) 1998-06-15
NZ248343A (en) 1995-03-28
US5597833A (en) 1997-01-28
KR940003936A (ko) 1994-03-14
NO179513B (no) 1996-07-15
SK86593A3 (en) 1994-06-08
IL106622A0 (en) 1993-12-08
CN1087337A (zh) 1994-06-01
CA2103521A1 (en) 1994-02-12
AU668574B2 (en) 1996-05-09

Similar Documents

Publication Publication Date Title
ES2625636T3 (es) Proceso para preparar inhibidores del metabolismo de nucleósidos
AU668574B2 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
ES2158876T3 (es) Derivado de galantamina, un procedimiento para su preparacion y su utilizacion como medicamento.
IE782359L (en) Phenylgylcine derivatives
CA2017135A1 (en) Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments
PT775117E (pt) Analogos de 2-nitroimidazole fluorinados para detectar celulas de tumor hipoxicas
AU581324B2 (en) Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
ES8305345A1 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".
IE56364B1 (en) Benzofuran derivatives
US4547509A (en) 5,6,7-Quinoline carbanilates and method of treating ischemic heart disease therewith
Zhang et al. Synthesis and biological evaluation of immunosuppressive agent DZ2002 and its stereoisomers
ATE43140T1 (de) Derivate von enzym-hemmender griseolsaeure und deren verwendung.
ES8800156A1 (es) Procedimiento para preparar nuevos derivados 3-piridilmetilnaftilicos
ES8205790A1 (es) Un procedimiento para la preparacion de derivados de imadazol n- sustituidos, o su sales de adicion de acido.
JPS5470830A (en) Color photographic material
ES8802573A1 (es) Procedimiento para la preparacion de un derivado del azol
FR2450106A1 (fr) Compositions pharmaceutiques ou veterinaires renfermant une quantite physiologiquement active d'une phenylethylamine, a activite de stimulation sexuelle